Mostrando 5 resultados de: 5
Publisher
Anales del Sistema Sanitario de Navarra(1)
Current Nutrition and Food Science(1)
Current Pharmaceutical Design(1)
Journal of Diabetes Research(1)
Nutrients(1)
Área temáticas
Enfermedades(4)
Fisiología humana(3)
Farmacología y terapéutica(1)
Salud y seguridad personal(1)
Origen
scopus(5)
Clinical and nutritional implications of kidney disease and COVID-19
ReviewAbstract: By the end of 2019 emerged a cluster of pneumonia that was caused by a novel SARS-CoV-2 virus. The dPalabras claves:acute kidney injury, Chronic kidney disease, Clinical nutrition, covid-19, nutritional, SARS-COV-2Autores:Albornoz C., Ariza D., Carrasquero R., D’marco L., Guerra-Torres X.E., Morillo V., Nava M., Valmore Bermúdez, Vasquez H.E.A.Fuentes:scopusAnti-aging effect of metformin: A molecular and therapeutical perspective
ReviewAbstract: Aging is a time-dependent inevitable process, in which cellular homeostasis is affected, which has aPalabras claves:ageing, Anti-ageing drugs, Geronto-protective properties, Metformin, Type 2 Diabetes mellitusAutores:Cano-Ponce C., D’marco L., Galbán N., Gomez Y., González M.C., Herazo Y., Morillo V., Nava M., Rojas M., Rojas-Quintero J., Torres W., Valmore Bermúdez, Velasco M.Fuentes:scopusPathogenic mechanisms of SARS-CoV-2 infection and kidney disease: a clinical and molecular perspective
ArticleAbstract: The SARS-CoV-2 infection has become as a worldwide public health emergency. It exhibits a variety ofPalabras claves:acute kidney injury, Angiotensin-conver-ting enzyme 2, Chronic kidney disease, covid-19, SARS-COV-2Autores:D’marco L., Guerra-Torres X.E., Lameda V., Manzano A., Medina O., Morillo V., Nava M., Parra H., Puchades M.J., Suarez M.K., Torres W., Valmore BermúdezFuentes:scopusMicrobiota and diabetes mellitus: Role of lipid mediators
ReviewAbstract: Diabetes Mellitus (DM) is an inflammatory clinical entity with different mechanisms involved in itsPalabras claves:DIABÉTES, dysbiosis, inflammation, lipopolysaccharides, microbiota, Short-chain fatty acidsAutores:Añez-Ramos R., Cano-Ponce C., Dávila L.C.A., González M.C., Martínez M.S., Morillo V., Navarro C., Rajotia A., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Torres W., Valmore BermúdezFuentes:scopusSGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence
ReviewAbstract: Background. Over the last few years, the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) aPalabras claves:Autores:D’marco L., Morillo V., Nava M., Ortega A., Parra H., Rojas-Quintero J., Suarez M.K., Teruel J.L., Valmore Bermúdez, Villasmil N.Fuentes:scopus